Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
7%
Adverse Event
12%
All Cause Mortality
7%
Antibiotic Agent
18%
Antibiotics
27%
Antidepressant
15%
Antihypertensive Agent
17%
Asthma
18%
Atopy
10%
Attention Deficit Disorder
11%
Beta Adrenergic Receptor Blocking Agent
8%
Cardiovascular Disease
15%
Cardiovascular Mortality
8%
Cardiovascular Risk
8%
Case-Control Study
23%
Chronic Obstructive Lung Disease
14%
Cohort Study
57%
Community Acquired Pneumonia
15%
CYP2D6
14%
Diabetes Mellitus
7%
Disease
27%
Fluoxetine
7%
Hemoglobin A1c
8%
Human Respiratory Syncytial Virus
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
21%
Infection
18%
Influenza Vaccine
32%
Influenza Virus
10%
Live Attenuated Influenza Vaccine
10%
Low Density Lipoprotein Cholesterol
8%
Metformin
8%
Non Insulin Dependent Diabetes Mellitus
44%
Normal Human
7%
Nortriptyline
10%
Observational Study
13%
Pharmacotherapy
8%
Placebo
11%
Pneumococcal Infection
10%
Pneumococcus Vaccine
20%
Prevalence
29%
Proton Pump Inhibitor
8%
Q Fever
9%
Randomized Controlled Trial
36%
Respiratory Tract Infection
9%
Seasonal Influenza
18%
Statin (Protein)
46%
Streptococcus Pneumoniae
8%
Urinary Tract Infection
19%
Vaccination Policy
100%
Venlafaxine
10%
Medicine and Dentistry
ACE Inhibitor
6%
Acute Otitis Media
9%
Antibiotics
14%
Asthma
7%
Cardiovascular Disease
10%
Cardiovascular System
8%
Case-Control Study
16%
Cohort Analysis
16%
Community-Acquired Pneumonia
13%
Cost-Effectiveness Analysis
25%
Diabetes
7%
Disease
17%
Drug Therapy
20%
General Medicine
19%
General Practitioner
9%
Health Care
23%
Health Care Cost
17%
Human Respiratory Syncytial Virus
5%
Infection
13%
Influenza A Virus (H1N1)
7%
Influenza Vaccination
61%
Influenza Vaccine
35%
Influenza Virus
6%
Kidney Graft
9%
Logistic Regression Analysis
9%
Maturity Onset Diabetes of the Young
16%
Meta-Analysis
16%
Nortriptyline
7%
Nursing Home
9%
Odds Ratio
31%
Otitis Media
6%
Patient with Diabetes
8%
Patient with Type 2 Diabetes
11%
Placebo
6%
Pneumococcal Infection
6%
Pneumococcus Vaccine
21%
Population
6%
Prevalence
10%
Primary Health Care
21%
Q Fever
10%
Quality Adjusted Life Year
7%
Quality of Life
7%
Randomized Controlled Trial
23%
Respiratory Tract Infection
7%
Seasonal Influenza
9%
Serotype
10%
Statin
7%
Streptococcus Pneumoniae
9%
Systematic Review
15%
Urinary Tract Infection
9%
Keyphrases
Adherence Rate
7%
Antidepressants
10%
Antihypertensive Drugs
10%
Asthma
7%
Atopic Disease
8%
Attention Deficit Hyperactivity Disorder
8%
Beta-blockers
6%
Cardiovascular Events
6%
Confidence Interval
35%
Cost-effectiveness
8%
Diabetes
6%
Drugs in Pregnancy
6%
During Pregnancy
8%
Dutch
18%
Fluoxetine
6%
General Practice
9%
General Practitioners
9%
Groningen
7%
Health-related Quality of Life
8%
Healthcare Workers
5%
Hospitalization
6%
Inception Cohort Study
11%
Indonesia
10%
Influenza
13%
Influenza Vaccination
23%
Influenza Vaccine
6%
Kidney Transplant Recipients
8%
Medication Adherence
5%
Methylphenidate
5%
Monotherapy
5%
Netherlands
39%
Non-adherence
9%
Non-persistence
5%
Odds Ratio
14%
Patients with Diabetes
10%
Pharmacist Intervention
5%
Pharmacy
7%
Pneumococcal Conjugate Vaccine
5%
Prescription Database
7%
Primary Care
9%
Primary Prevention
7%
Prospective Cohort Study
6%
Proton Pump Inhibitors
9%
Retrospective Cohort Study
6%
Statin Therapy
18%
Statin Use
7%
Statins
17%
Type 2 Diabetes Mellitus (T2DM)
5%
Type 2 Diabetic Patients
17%
Vaccination
12%
